Time course of late rectal toxicity after radiation therapy for prostate cancer

Prostate Cancer and Prostatic Diseases

Volumn 13, Issue 2, 2010, Pages 138-143

  Odrazka, K ^a,b,c   Dolezel, M ^a,c   Vanasek, J ^a   Vaculikova, M ^a   Zouhar, M ^d   Sefrova, J ^d   Paluska, P ^d   Vosmik, M ^d   Kohlova, T ^d   Kolarova, I ^a   MacIngova, Z ^d   Navratil, P ^d   Brodak, M ^d   Prosvic, P ^e  

^a Pardubice Regional Hospital   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c IPVZ   (Czech Republic)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^e Regional Hospital Nachod   (Czech Republic)

Author keywords

Late toxicity; Radiation therapy; Rectal toxicity

Indexed keywords

ANTIANDROGEN; CINCHOCAINE; CODEINE; DIOSMIN; DIPHENOXYLATE; GONADORELIN DERIVATIVE; IBUPROFEN; MESALAZINE; TRIBENOSIDE;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARGON PLASMA COAGULATION; ARTICLE; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COLONOSCOPY; COMPUTER ASSISTED RADIOTHERAPY; DIARRHEA; DISEASE COURSE; FECES INCONTINENCE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PAIN; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; RECTUM INJURY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL APPROACH; TELANGIECTASIA; TENESMUS; TRANSURETHRAL RESECTION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; DIARRHEA; FECAL INCONTINENCE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RECTUM; TIME FACTORS;

EID: 77952547329     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/pcan.2009.56     Document Type: Article

References (21)

1. Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A et al. Long term tolerance of high dose three-dimensional radiotherapy in patients with localized prostate carcinoma. Cancer 1999;85:2460-2468.
2. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 2000;48:635-642.
3. Michalski JM, Winter K, Purdy JA, Parliament M, Wong H, Perez CA et al. Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 2005;62:706-713.
4. Peeters S, Heemsbergen W, van Putten W, Slot A, Tabak H, Mens JW et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68-78 Gy. Int J Radiat Oncol Biol Phys 2005;61:1019-1034.
5. Goldner G, Bombosch V, Geinitz H, Becker G, Wachter S, Glocker S et al. Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. Strahlenther Onkol 2009;185:94-100.
6. Abdalla I, Ignacio L, Vaida F, Mei-Hsu, Awan A, Jani A et al. Evolution of toxicity after conformal radiotherapy for prostate cancer. Prostate Cancer Prostatic Dis 2002;5:296-303.
7. Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensitymodulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124-1129.
8. Karlsdottir A, Muren LP, Wentzel-Larsen T, Dahl O. Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity. Int J Radiat Oncol Biol Phys 2008;70:1478-1486.
9. Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I et al. Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;54:1314-1321.
10. De Meerleer GO, Fonteyne VH, Vakaet L, Villeirs GM, Denoyette L, Verbaeys A et al. Intensity-modulated radiation therapy for prostate cancer: late morbidity and results on biochemical control. Radiother Oncol 2007;82:160-166.
11. Lin C, Turner S, Mai T, Kneebone A, Gebski V. Late rectal and urinary toxicity from conformal, dose-escalated radiation therapy for prostate cancer: a prospective study of 402 patients. Australas Radiol 2007;51:578-583.
12. Christie D, Denham J, Steigler A, Lamb D, Turner S, Mameghan H et al. Delayed rectal and urinary symptomatology in patients treated for prostate cancer by radiotherapy with or without short term neo-adjuvant androgen deprivation. Radiother Oncol 2005;77:117-125.
13. Odrazka K, Vanasek J, Vaculikova M, Petera J, Zouhar M, Zoul Z et al. Conformal radiotherapy for prostate cancer-longer duration of acute genitourinary toxicity in patients with prior history of invasive urological procedure. Acta Oncol 2001;40:810-815.
14. Hanlon AL, Schultheiss TE, Hunt MA, Movsas B, Peter RS, Hanks GE. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys 1997;38:59-63.
15. Fonteyne V, De Neve W, Villeirs G, De Wagter C, De Meerleer G. Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: the need for adapting toxicity scales and the appearance of the sigmoid as co-responsible organ for lower intestinal toxicity. Radiother Oncol 2007;84:156-163.
16. Fiorino C, Fellin G, Rancati T, Vavassori V, Bianchi C, Borca VC et al. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys 2008;70:1130-1137.
17. Capp A, Inostroza-Ponta M, Bill D, Moscato P, Lai C, Christie D et al. Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial. Radiother Oncol 2009;90:400-407.
18. O'Brien PC, Hamilton CS, Denham JW, Gourlay R, Franklin C I V. Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004;58:75-80.
19. Sebastian S, O'Connor H, O'Morain C, Buckley M. Argon plasma coagulation as first-line treatment for chronic radiation proctopathy. J Gastroenterol Hepatol 2004;19:1169-1173.
20. Yeoh EE, Holloway RH, Fraser RJ, Botten RJ, Di Matteo AC, Moore JW et al. Anorectal dysfunction increases with time following radiation therapy for carcinoma of the prostate. Am J Gastroenterol 2004;99:361-369.
21. Vordermark D, Schwab M, Ness-Dourdoumas R, Sailer M, Flentje M, Koelbl O. Association of anorectal dose-volume histograms and impaired fecal continence after 3D conformal radiotherapy for carcinoma of the prostate. Radiother Oncol 2003;69:209-214.